Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Volume Increase – Time to Buy?

Posted by Brian Himes on Jul 2nd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) saw strong trading volume on Thursday . 271,047 shares traded hands during mid-day trading, an increase of 113% from the previous session’s volume of 127,418 shares.The stock last traded at $12.1967 and had previously closed at $11.72.

Wall Street Analyst Weigh In

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research note on Tuesday, June 23rd. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Fresenius SE & Co. currently has a consensus rating of “Buy”.

Get Our Latest Analysis on FSNUY

Fresenius SE & Co. Stock Performance

The business’s 50-day simple moving average is $11.41 and its two-hundred day simple moving average is $13.10. The firm has a market cap of $27.22 billion, a price-to-earnings ratio of 16.11 and a beta of 0.63. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 0.41.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The business had revenue of $6.75 billion for the quarter, compared to analyst estimates of $6.79 billion. As a group, sell-side analysts expect that Fresenius SE & Co. will post 1.03 earnings per share for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.